We are Nanoscope Instruments Inc., a research-driven biomedical technology company dedicated to advancing vision science through innovative imaging and optical solutions. Based in the Dallas–Fort Worth area, we develop advanced instruments that integrate optical coherence tomography (OCT) with targeted optical stimulation and functional measurement, enabling researchers and clinicians to visualize and analyze cellular activity in real time. Our platforms support both in vivo and ex vivo applications, providing flexible, scalable systems tailored to a wide range of experimental and clinical needs. We are committed to delivering precise, reliable, and user-friendly tools that help advance understanding of retinal health, neural signaling, and disease progression. By combining cutting-edge engineering with practical usability, we empower the scientific community to accelerate discovery, drive innovation, and improve outcomes in vision and biomedical research worldwide.
Lions World Vision Institute
Lions World Vision Institute leverages industry leading expertise, resources, and groundbreaking innovations designed to streamline cornea transplant procedures and improve clinical outcomes. Experience our latest innovations, TransplantREADY Endo-In DMEK, DSAEK and OptiGraft CAIRS during hands-on wet labs and informational presentations.
Jorvec Corp.
Advanced Electrophysiology and Multi-sensory Systems for Human and Rodent Models Stop by Jorvec’s booth and see our advanced visual evoked potential VEP systems and our innovative pattern electroretinogram PERG system with its unique display tablets for high rate visual stimulation and our integrated animal holder. Learn how our technologies can facilitate earlier detection and monitoring of glaucoma, LHON, TBI and other optic neuropathies. We also offer hybrid, multi-sensory systems capable of recording auditory evoked responses (ABR, AEP, OAE, VEMP), other sensory modalities (somatosensory) and event related potentials (P300), in addition to the standard visual modalities all within one device! Allow us to configure a single device capable of broad cognitive assessment. We look forward to the opportunity to discuss how our instruments and services can meet your specific animal and human research needs.
Gene Tools, LLC
Gene Tools designs and manufactures Morpholino antisense oligos (PMOs). Morpholinos bind to complementary RNA and get in the way of processes such as translation, splicing and miRNA activity. Morpholinos are the premier knockdown tools used in developmental biology labs, the best RNA-blocking reagents for cells in culture and, as Vivo-Morpholinos, the most specific delivery-enhanced oligos available for animal models. Backed by Ph.D.-level customer support, Gene Tools sells research quantities of Morpholinos world-wide. | Gene Tools manufactures Morpholino oligos for blocking translation, modifying splicing or inhibiting miRNA activity. Morpholinos are effective, specific, stable and non-toxic. They are used in cell cultures, embryos or, as Vivo-Morpholinos, in adult animals. Gene Tools also markets products for delivery of Morpholinos into cell cultures, including our Endo-Porter endosomal release agent. Dr. Jim Summerton founded the pioneering antisense company Antivirals Inc. (now AVI BioPharma Inc.) in 1980 to develop antisense therapeutics and founded Gene Tools, LLC in 1997 to supply Morpholino oligos to researchers worldwide. Backed by Ph.D.-level customer support, Gene Tools designs and synthesizes Morpholinos and delivery reagents
Garner Bio
Garner BioSolutions Inc. is a woman & minority owned biotech business specializing in biospecimen procurement for research use. By leveraging our global procurement networks and stringent quality standards we can source meticulously characterized, ethnically diverse biospecimens in an affordable way. Our advanced procurement processes ensure the integrity and traceability of each specimen, providing researchers with invaluable resources for molecular studies, biomarker discovery, and therapeutic development. Explore our comprehensive suite of biospecimen services at garnerbio.com to propel your research endeavors to new heights.
Etaluma, Inc.
Etaluma is a San Diego bio-imaging company offering incubator-based high performance multi-channel fluorescence microscopy. Our specialty is time-lapse live cell imaging in an incubator for days and even weeks to continuously visualize essential data for migration assays, wound healing, corneal epithelial cells, angiogenesis, and retinal cell behavior. Our short and simple optics path yields resolution and sensitivity that beats the big four. We have removed the oculars, the arc lamp, the filter wheels and the CCD from the traditional microscope; we instead use LEDs, CMOS cameras, and multi-bandpass filter sets to increase the sensitivity and resolution while allowing all of our models to be used in incubators, hypoxia chambers, and on your bench. Phase contrast, bright field and dark field transmitted modes are included. The LumaviewPro application is based on Python and is available as open source and includes a RESTful API.
Charles River
Charles River is a global preclinical oncology CRO delivering end to end oncology and immuno oncology drug discovery, from target identification and validation through IND enabling and clinical. We partner with academic, biotechnology, and pharmaceutical companies to advance innovative cancer therapies. In 2025, Charles River supported 87% of FDA-approved oncology therapies, including first-in-class and best-in-class drugs. Our capabilities span small molecules, biologics, antibodies, antibody drug conjugates (ADCs), immunotherapies, checkpoint inhibitors, cell therapies, and gene therapies. Our research model (RMS) portfolio includes immunodeficient mice and rats, PBMC and CD34+ humanized mouse models, end-to-end support from colony management for Genetically Engineered Model (GEM), including transgenic model generation and breeding, to vivarium rental or customizable onsite services (staffing, consulting, training), and CRADL® support in global biohubs. Our oncology platforms include 1,700+ xenograft models (PDX, CDX, syngeneic, humanized), covering 45+ cancer indications across solid tumors, hematologic, and pediatric cancers. Integrated in vitro, ex vivo, NAMs and 3D tumor models—including organoids, tumoroids, and tissue microarrays (TMAs)- support efficacy, PK/PD, biomarker, and translational decision making. Multi omics, AI enabled analytics, and strategic CMC/CDMO capabilities help teams plan manufacturing earlier, strengthen regulatory readiness, improve study design, reduce risk, and accelerate candidate to patients. Learn more at criver.com/cancer-research-annual-meeting-2026 | Charles River has supported researchers in advancing ocular therapies for more than two decades, with a comprehensive suite of capabilities designed to meet your program needs. We help you progress small molecules, biologics, gene and cell therapies, and implantable devices from concept to clinic with confidence. Our team provides rigorous efficacy, distribution, and safety assessments supported by state-of-the-art imaging, functional evaluations, and New Approach Methodologies (NAMs) to help you improve predictability and generate high-quality data for global regulatory submissions. We also assess the ocular effects of systemic compounds for non-ocular indications, helping you refine study design, manage timelines and resources, and reduce animal use. We are committed to partnering with you at every stage to help bring meaningful treatments to patients worldwide because every moment matters. | Charles River provides essential products and services to support pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide in accelerating research and drug development. As a leader in scientific innovation, we are deeply committed to pioneering alternative methods that drive discovery while reducing reliance on traditional models. By embracing cutting-edge technologies and forward-thinking approaches, we enhance preclinical and clinical research. Our dedicated employees focus on delivering precisely what our clients need to improve, innovate, and expedite the discovery, early-stage development, and safe manufacture of new therapies for patients—because every moment matters. Learn more at www.criver.com. | Charles River is committed to helping companies like yours get your product to market safely and efficiently. Whether you’re still in development or already manufacturing, our Safety Assessment and Microbial Solutions services provide state-of-the-art technology and expert regulatory advice that will help you anticipate challenges, avoid roadblocks, and make better decisions.